Melazyme: scalable microbial fermentation for natural sweet proteins
Melazyme offers a cost-effective microbial fermentation platform for producing natural sweet proteins like Brazzein, which is up to 2,000x sweeter than sugar. It aims to address industry challenges in cost and scalability, with a focus on quality and partnership-driven market development.
Overview
Melazyme is a cutting-edge microbial fermentation platform developed to produce natural, high-intensity sweet proteins. The platform's first target, Brazzein, is an exceptionally sweet protein, up to 2,000 times sweeter than sugar, offering a clean taste and heat stability. This innovation addresses the industry's pressing need for cost-effective and scalable sweetener solutions, positioning itself as a leader in sweet protein production.
Technical specifications
- Target Molecule: Brazzein, known for its clean taste and high heat stability
- Production Method: Fermentation using a filamentous fungi with a GRAS history
- Technical Metrics: Industry-leading titers and productivity, scalable to industry needs
- Partnership Model: Focus on strain engineering, process development, and manufacturing with market development through partnerships
- Future Plans: Development of additional sweet proteins like Monellin, ongoing strain optimization, and cost reduction strategies
Technology readiness level
Melazyme has reached a Technology Readiness Level of 6, indicating that it has been validated in relevant environments and is ready for pilot-scale production. The platform is set for commercial launch in 2026, with ongoing regulatory submissions to ensure compliance and market readiness.
delivered to your inbox.